Genfit

This study tested a drug called VS-01, given into the belly, for people with severe liver failure and fluid buildup (ascites). The goal was to see if it could improve liver function and survival when added to standard care. The trial was stopped early and included only 15 adults.

This study tested an experimental drug called VS-01 for people with liver cirrhosis who develop a serious brain condition called hepatic encephalopathy. The goal was to see if adding VS-01 to standard care could help patients recover faster. Only 3 people were enrolled before the…